FIELD: chemistry, medicine.
SUBSTANCE: claimed invention relates to main fatty acid ethers of general formula R1-O-CO-A or their pharmaceutically acceptable salts, where R1 represents C10-C24alkenyl, and A represents residue, containing at least one acyclic or cyclic aminogroup and/or at least one heteroaromatic ring, which contains tertiary or quaternary nitrogen atom, and to their application as anti-inflammation or immunomodulatory medications in particular for treatment of immune-mediated inflammation, as well as adjuvants for antigens, participating in cell and humoral response.
EFFECT: invention ensures enhancing composition and treatment method efficiency.
180 cl, 22 ex, 4 tbl, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF CRTH2 ANTAGONISTS IN THERAPY | 2004 |
|
RU2412934C2 |
| PHARMACEUTIC PREPARATION CONTAINING CARBOXYPEPTIDASE U INHIBITOR AND THAT OF THROMBIN | 2000 |
|
RU2242992C2 |
| PYRAZOLINE DIONE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | 2010 |
|
RU2569855C2 |
| COMPOUNDS BOUND WITH BIR DOMAIN OF IAP | 2007 |
|
RU2446170C2 |
| AZAINDOLES, USEFUL AS INHIBITORS OF JAK AND OTHER PROTEINKINASES | 2005 |
|
RU2403252C2 |
| SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR MODULATORS AND USING THEM FOR TREATING MUSCULAR TISSUE INFLAMMATION | 2009 |
|
RU2521286C2 |
| PYRIMIDINE COMPOUND | 2016 |
|
RU2759917C2 |
| UREA DERIVATIVES AND THEIR APPLICATION AS INHIBITORS OF FATTY ACIDS CONNECTING PROTEIN | 2014 |
|
RU2642454C2 |
| ROR-GAMMA MODULATORS | 2017 |
|
RU2753490C2 |
| SOME CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2009 |
|
RU2537549C2 |
